Any questions? Contact us+49 761-389 49-0

Seraseq™ Tumor Mutation DNA Mix v2 AF7 HC

Seraseq™ Tumor Mutation DNA Mix v2 AF7 HC

Seraseq™ Tumor Mutation DNA Mix v2 AF7 HC

#0710-0095 A multiplexed mixture of actionable biosynthetic DNA targets precisely blended with a single, well-characterized genomic background.
€2,410.00 *

Prices plus VAT plus shipping costs

Delivery time 7 Workdays

Size: 1 x 25 µl (25 ng/µl)
  • 0710-0095
Single-vial format for daily run use, 40 unique multiplexed variants across 28 genes, 20 SNVs, 5... more
Single-vial format for daily run use, 40 unique multiplexed variants across 28 genes, 20 SNVs, 5 SNVs that are part of homopolymers, 13 indels, 2 SVs. Mutation targets quantitated with digital PCR, well-characterized GM24385 human genomic DNA as background wild-type material. Manufactured within cGMP-compliant, ISO 13485-certified facilities. The Seraseq Tumor Mutation Mix-II DNA Mix v2 (AF7) HC is formulated for use with targeted next-generation sequencing (NGS) assays that detect mutations in key oncogenes and tumor suppressor genes. The Seraseq Tumor Mutation Mix-II DNA Mix v2 (AF7) HC is intended as a quality reference material for translational and disease research testing to monitor library preparation, sequencing, and variant allele detection under a given set of bioinformatics pipeline parameters.

For details click here.
PROPERTIES
storage temperature: -20°
shipping method: dry ice
regulatory status: RUO
Viewed